Скачать или смотреть CereTherapia P.I.R.F. Neuromodulation Pitch

Today, over 1 billion people worldwide suffer from neurological disorders, and the numbers are rising. Conventional treatments, such as deep brain stimulation, require invasive surgery, while non-invasive methods like TMS and tDCS fail to reach deep brain structures and offer poor spatial resolution. These limitations lead to suboptimal outcomes, increased risks, and higher healthcare costs. It's time for a change.

Now imagine a world where we can precisely target and treat neurological conditions without invasive surgery or the limitations of current non-invasive methods. That's the world we're creating with P.I.R.F., the groundbreaking ultrasonic neuromodulation technology developed by Stanford researchers.

PIRF has the potential to transform the lives of millions suffering from neurological conditions such as depression, Parkinson's, epilepsy, and chronic pain. By providing a non-invasive, precise, and personalized treatment option, we can improve patient outcomes, reduce healthcare costs, and unlock new possibilities in neuroscience research.

The global neuromodulation market is expected to reach $13.3 billion dollars by 2025, and PIRF is poised to capture a significant share. Our technology addresses the unmet needs of multiple target segments, including hospitals, clinics, research institutions, and home healthcare.

With a clear path to market and a strong IP portfolio, we're ready to disrupt the industry. Join us in our mission to revolutionize neuromodulation and improve the lives of millions worldwide.

With your support, we can bring PIRF to market and make a lasting impact on brain health. Together, let's unlock the potential of the brain and create a brighter future for all.

Video is part of The Center for Advancing Innovation: The Global Health Innovation Challenge II.

For more information, contact us at [email protected]